Martin Reck, MD, PhD, Discusses NSCLC Data of Interest From 2021 ASCOByMartin Reck, MD, PhDJune 9th 2021Reck mentioned the IMpower010 and CheckMate 816 trials investigating treatment options for patients with non-small cell lung cancer.